GlassScriptPhysician profile
Eve Liu
NPI 1093388928
$1,995.72
in general payments reported to CMS, 2019-2025
19 companies · $994 in 2025
The $994 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $327 · 2023: $98.26 · 2024: $577 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,668.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $264.06 | 2022-2025 | Epclusa |
| Amgen INC. | $245.76 | 2024-2025 | Otezla, Otezla |
| Lilly USA, LLC | $167.53 | 2022 | |
| Grifols USA, LLC | $125.65 | 2024 | Xembify |
| Merck Sharp & Dohme LLC | $122.88 | 2025 | Capvaxive |
| Abbvie INC. | $122.88 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $115.43 | 2025 | Camzyos |
| Phadia US INC. | $105.78 | 2024 | Immunocap |
| Novo Nordisk INC | $104.12 | 2025 | Ozempic |
| Kyowa Kirin, INC. | $99.66 | 2024 | |
| Genzyme Corporation | $98.26 | 2023 | |
| Jazz Pharmaceuticals INC. | $94.72 | 2025 | |
| Alkermes, INC. | $94.08 | 2025 | Lybalvi |
| Novartis Pharmaceuticals Corporation | $93.87 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $80.55 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $17.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.65 | 2022 | |
| Scynexis, INC. | $15.02 | 2022 | |
| Sunovion Pharmaceuticals INC. | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eve Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.